Old Web
English
Sign In
Acemap
>
authorDetail
>
Hiromichi Sugimoto
Hiromichi Sugimoto
Takeda Pharmaceutical Company
Stereochemistry
Indoline
Chemistry
GPR119
Lead compound
2
Papers
21
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Discovery of a Novel Series of Indolinylpyrimidine-based GPR119 Agonists: Elimination of Ether-a-go-go-related Gene Liability Using a Hydrogen Bond acceptor-Focused Approach
2021
Bioorganic & Medicinal Chemistry
Masahiro Kamaura
Osamu Kubo
Hiromichi Sugimoto
Naoyoshi Noguchi
Hirohisa Miyashita
Shin-Ichi Abe
Kae Matsuda
Yoshiyuki Tsujihata
Tomoyuki Odani
Shinji Iwasaki
Toshiki Murata
Kenjiro Sato
Show All
Source
Cite
Save
Citations (1)
Discovery of a novel series of indoline carbamate and indolinylpyrimidine derivatives as potent GPR119 agonists.
2014
Bioorganic & Medicinal Chemistry
Kenjiro Sato
Hiromichi Sugimoto
Kentaro Rikimaru
Hiroshi Imoto
Masahiro Kamaura
Nobuyuki Negoro
Yoshiyuki Tsujihata
Hirohisa Miyashita
Tomoyuki Odani
Toshiki Murata
Show All
Source
Cite
Save
Citations (20)
1